This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
In this double-blind, placebo-controlled trial, 159 pregnant women with a family history of atopic disease (ie, ≥ 1 parent or older sibling with allergic rhinitis, atopic dermatitis, or asthma) recruited from prenatal clinics in Finland were randomized to receive either Lactobacillus GG (1 X 1010 colony-forming units) or placebo daily for 2–4 weeks before expected delivery. For 6 months after delivery, breastfeeding mothers either continued to take the supplement or could administer it to the infant in liquid form. Children were examined during the neonatal …
Individual Login
Institutional Login
You may be able to gain access using your login credentials for your institution. Contact your librarian or administrator if you do not have a username and password.
Log in through your institution
Purchase access
In this issue
Jump to section
Related Articles
Cited By...
- No citing articles found.